Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-19 Other |
2025-03-20 4:06 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
20,000 | $6.155 | 120,151 (Direct) |
View |
| 2025-02-09 Exercise |
2025-02-11 6:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
7,000 | $0 | 100,151 (Direct) |
View |
| 2025-02-09 Tax Withholding |
2025-02-11 6:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
2,055 | $6.495 | 100,151 (Direct) |
View |
| 2025-01-05 Tax Withholding |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
10,007 | $8.26 | 812,746 (Direct) |
View |
| 2025-01-03 Option Award |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
585,000 | $0 | 812,746 (Direct) |
View |
| 2025-01-05 Exercise |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
50,794 | $0 | 812,746 (Direct) |
View |
| 2025-01-06 Tax Withholding |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
6,108 | $8.68 | 812,746 (Direct) |
View |
| 2024-07-10 Exercise |
2024-07-12 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
16,666 | $0 | 93,861 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-07-12 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
8,059 | $8.69 | 93,861 (Direct) |
View |
| 2024-02-27 Gift |
2024-02-28 4:46 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
2,500 | $0 | 51,920 (Direct) |
View |
| 2024-02-20 Gift |
2024-02-22 5:08 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
20,000 | $0 | 51,920 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 5:37 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
11,967 | $0 | 58,920 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:37 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
3,533 | $28.8 | 58,920 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 9:07 pm |
N/A 2034-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
270,000 | $0 | 355,073 (Direct) |
View |
| 2024-01-06 Exercise |
2024-01-09 9:07 pm |
N/A 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
20,793 | $0 | 355,073 (Direct) |
View |
| 2024-01-06 Tax Withholding |
2024-01-09 9:07 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
6,528 | $20.4 | 355,073 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 6:53 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-06-20 Option Award |
2023-06-22 09:13 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO |
62,380 | $0 | 62,380 (Direct) |
View |
| 2023-02-09 Tax Withholding |
2023-02-13 5:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO |
4,148 | $4.17 | 48,188 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 5:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO |
11,967 | $0 | 48,188 (Direct) |
View |
| 2023-01-06 Option Award |
2023-01-10 5:56 pm |
N/A 2033-01-05 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO |
124,755 | $0 | 124,755 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 08:38 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
4,479 | $5.42 | 21,402 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 08:38 am |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
15,258 | $0 | 21,402 (Direct) |
View |
| 2022-09-07 Option Award |
2022-09-09 4:19 pm |
N/A 2032-09-06 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
65,300 | $0 | 65,300 (Direct) |
View |
| 2021-11-01 Option Award(A) |
2022-09-09 4:09 pm |
N/A 2031-11-01 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
239,700 | $0 | 239,700 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 6:37 pm |
N/A 2032-06-22 |
Sesen Bio Inc. | SESN | Duker Jay S. Director |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 4:41 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
106,000 | $0 | 126,557 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 4:41 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
4,966 | $0 | 126,557 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-03 5:50 pm |
2022-11-01 2031-11-01 |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
320,258 | $0 | 320,258 (Direct) |
View |
Ownership |
2021-11-03 5:48 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer |
0 | $0 | 119,873 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 6:18 pm |
N/A 2031-05-03 |
Sesen Bio Inc. | SESN | Duker Jay S. Director |
92,500 | $0 | 92,500 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 5:44 pm |
N/A 2030-05-06 |
Sesen Bio Inc. | SESN | Duker Jay S. Director |
59,000 | $0 | 59,000 (Direct) |
View |